Revenue: As of FY2025, the actual value is USD 7.219 B, missing the estimate of USD 7.246 B.EPS: As of FY2025, the actual value is USD 11.18, beating the estimate of USD 11.1175.EBIT: As of FY2025, the actual value is USD 1.053 B.<h4>Overall Financial Performance</h4>Ingredion Incorporated’s Net income attributable to Ingredion increased to $729 million in 2025, from $647 million in 2024. Operating income rose by 15% to $1,016 million in 2025, compared to $883 million in 2024. Net sales decreased by 3% to $7.2 billion in 2025, down from $7.4 billion in 2024. The gross profit margin increased to 25% in 2025 from 24% in 2024. Operating expenses increased by 4% to $815 million in 2025, from $782 million in 2024, remaining at 11% of net sales for both years. Other operating income, net, increased to $24 million in 2025, compared to $1 million in 2024. Restructuring/impairment charges significantly decreased to $21 million in 2025 from $127 million in 2024. Financing costs also decreased to $37 million in 2025 from $39 million in 2024. There was no net gain on the sale of business in 2025, compared to a -$90 million gain in 2024. Other non-operating expense increased to $5 million in 2025 from $3 million in 2024.<h4>Segment Revenue and Operating Income</h4><ul><li>Texture &amp; Healthful Solutions (T&amp;HS):<ul><li>Net sales increased by 1% to $2,397 million in 2025 from $2,366 million in 2024.</li><li>Operating income increased by 16% to $405 million in 2025 from $350 million in 2024.</li></ul></li><li>Food &amp; Industrial Ingredients–LATAM (F&amp;II–LATAM):<ul><li>Net sales decreased by 4% to $2,341 million in 2025 from $2,450 million in 2024.</li><li>Operating income increased by 2% to $493 million in 2025 from $483 million in 2024.</li></ul></li><li>Food &amp; Industrial Ingredients–U.S./Canada (F&amp;II–U.S./Canada):<ul><li>Net sales decreased by 7% to $2,013 million in 2025 from $2,155 million in 2024.</li><li>Operating income decreased by 16% to $315 million in 2025 from $373 million in 2024.</li></ul></li><li>All Other:<ul><li>Net sales increased by 2% to $468 million in 2025 from $459 million in 2024.</li><li>Operating loss improved to -$2 million in 2025 from -$22 million in 2024.</li></ul></li></ul><h4>Cash Flow</h4>Cash provided by operating activities decreased to $944 million in 2025 from $1,436 million in 2024. Cash used for investing activities increased to $444 million in 2025 from $47 million in 2024, reflecting $433 million in capital expenditures and mechanical stores purchases in 2025, compared to $295 million in 2024. Cash used for financing activities was $491 million in 2025, compared to $765 million in 2024. Cash dividends paid were $211 million in 2025 and $210 million in 2024. Ingredion Incorporated repurchased 1.8 million shares of common stock at a net cost of $224 million in 2025.<h4>Liquidity and Debt</h4>As of December 31, 2025, Ingredion Incorporated’s total available liquidity was $3.9 billion, comprising $1.6 billion in domestic liquidity and $2.3 billion in international liquidity. Total debt outstanding was $1.8 billion for both 2025 and 2024, with a weighted average interest rate of 4.0% for both years.<h4>Key Financial Performance Metrics</h4>Ingredion Incorporated’s Adjusted Return on Invested Capital (Adjusted ROIC) was 15.5% in 2025, up from 14.8% in 2024. The Net Debt to Adjusted EBITDA ratio was 0.6 in 2025, down from 0.7 in 2024.<h4>Outlook / Guidance</h4>Ingredion Incorporated anticipates capital investment commitments for 2026 to be approximately $400 million to $440 million. The amount of commercial paper outstanding under its program is expected to fluctuate in 2026. The company also plans to complete the purchase of remaining PureCircle shares in the first quarter of 2026 and expects to receive a final consideration payment of approximately $12 million from the South Korea business sale in February 2027.

Ingredion | 10-K: FY2025 Revenue Misses Estimate at USD 7.219 B